Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessment of transparency and selective reporting of interventional trials studying colorectal cancer ; volume:22 ; number:1 ; day:15 ; month:3 ; year:2022 ; pages:1-9 ; date:12.2022
BMC cancer ; 22, Heft 1 (15.3.2022), 1-9, 12.2022
- Creator
-
Pellat, Anna
Boutron, Isabelle
Ravaud, Philippe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09334-5
- URN
-
urn:nbn:de:101:1-2022060722302944713143
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pellat, Anna
- Boutron, Isabelle
- Ravaud, Philippe
- SpringerLink (Online service)
Other Objects (12)
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Economic consequences of reporting transparency
Economic consequences of reporting transparency
Accountability, research transparency and data reporting
Corporate carbon reporting: Improving transparency and accountability
Corporate carbon reporting: Improving transparency and accountability
Reporting transparency: making the ethical mandate explicit
Corporate carbon reporting: Improving transparency and accountability
Transparency in corporate reporting : assessing emerging market multinationals
Essays on financial reporting incentives and bank transparency
Transparency in corporate reporting : assessing the world's largest companies
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Economic consequences of reporting transparency
Economic consequences of reporting transparency
Accountability, research transparency and data reporting
Corporate carbon reporting: Improving transparency and accountability
Corporate carbon reporting: Improving transparency and accountability
Reporting transparency: making the ethical mandate explicit
Corporate carbon reporting: Improving transparency and accountability
Transparency in corporate reporting : assessing emerging market multinationals
Essays on financial reporting incentives and bank transparency
Transparency in corporate reporting : assessing the world's largest companies
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Economic consequences of reporting transparency
Economic consequences of reporting transparency
Accountability, research transparency and data reporting
Corporate carbon reporting: Improving transparency and accountability
Corporate carbon reporting: Improving transparency and accountability
Reporting transparency: making the ethical mandate explicit
Corporate carbon reporting: Improving transparency and accountability
Transparency in corporate reporting : assessing emerging market multinationals
Essays on financial reporting incentives and bank transparency